Citations

Citations to this article as recorded by  

• A systematic literature review and meta‐analysis of real‐world evidence on commercially available automated insulin delivery systems in people with type 1 diabetes
  Johannes Pöhlmann, Jayne Smith‐Palmer, Erik H. Serné, Anna‐Kaisa Tuomaala, Johan Jendle, Pratik Choudhary, Emanuele Bosi, Viswanathan Mohan, Tim van den Heuvel, Ohad Cohen, Richard F. Pollock
  Diabetes, Obesity and Metabolism.2026; 28(S1): 13.     CrossRef
• A nationwide 12‐month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events
  Jean‐Pierre Riveline, Jean‐Baptiste Julla, Elisabeth Bonnemaison, Michael Joubert, Sandrine Lablanche, Agnès Sola Gazagnes, Delphine Demarsy, Didier Gouet, Pauline Schaepelynck, Chloé Amouyal, Fabienne Dalla Vale, Anne Schletzer‐Mari, Sylvaine Clavel, Ann
  Diabetes, Obesity and Metabolism.2026; 28(2): 1179.     CrossRef
• Impact of stepwise diabetes technology advances in older adults with type 1 diabetes: A systematic review and meta‐analysis of randomised trials
  Mengyun Lei, Yongwen Zhou, Ying Ni, Zhiqin Lin, Qiongyan Lin, Ping Ling, Daizhi Yang, Wen Xu, Hongrong Deng, Jinhua Yan
  Diabetes, Obesity and Metabolism.2026; 28(3): 1750.     CrossRef
• 7. Diabetes Technology: Standards of Care in Diabetes—2026
  Mandeep Bajaj, Rozalina G. McCoy, Kirthikaa Balapattabi, Raveendhara R. Bannuru, Natalie J. Bellini, Allison K. Bennett, Elizabeth A. Beverly, Kathaleen Briggs Early, Sathyavathi ChallaSivaKanaka, Justin B. Echouffo-Tcheugui, Brendan M. Everett, Rajesh Ga
  Diabetes Care.2026; 49(Supplement): S150.     CrossRef
• Advancing Type 1 Diabetes Management: Integrating Novel Therapies, Technologies, and Adjunctive Approaches
  Jennifer R. Snaith, Phoom Narongkiatikhun, Petter Bjornstad, Jerry R. Greenfield, Kalie L. Tommerdahl
  Diabetes Care.2026; 49(1): 7.     CrossRef
• In‐flight glycaemic control using automated insulin delivery systems: A within‐subject comparative pilot study
  Renald Meçani, Silvia Basta, Petra M. Baumann, Monika Cigler, Omaima el Hakouni, Daniel A. Hochfellner, Fariba Shojaee‐Moradie, Ka Siu Fan, Dietrich Tews, Thomas R. Pieber, David Russell‐Jones, Chantal Mathieu, Gerd Koehler, Julia K. Mader
  Diabetes, Obesity and Metabolism.2026; 28(3): 2159.     CrossRef
• Use of hybrid closed-loop insulin pump in pancreatogenic diabetes following necrotizing hemorrhagic pancreatitis: a case report
  Laura Soldovieri, Gea Ciccarelli, Michela Brunetti, Gianfranco Di Giuseppe, Emanuele Gentile, Sara Sofia De Lucia, Antonio Gasbarrini, Alfredo Pontecorvi, Andrea Giaccari, Enrico Celestino Nista, Teresa Mezza
  Frontiers in Clinical Diabetes and Healthcare.2026;[Epub]     CrossRef
• Automated Insulin Delivery Associated with Superior Glycemic Outcomes in Type 1 Diabetes: A Swedish National Registry Analysis
  Fredrik Ståhl, Jarl Hellman, Charlotte Ekelund
  Diabetes Technology & Therapeutics.2026; 28(8): 808.     CrossRef
• Insights for personalized choice of a hybrid closed–loop system: an expert opinion
  S. Di Molfetta, F. Boscari, A. Rossi, A. Girelli, G. Lepore, L. Bozzetto, C. Irace, L. Laviola, D. Bruttomesso
  Diabetes Research and Clinical Practice.2026; 233: 113120.     CrossRef
• Use of Inhaled Insulin with Automated Insulin Delivery Systems
  Eda Cengiz, Roy W. Beck
  Diabetes Technology & Therapeutics.2026;[Epub]     CrossRef
• Recent Advances in the Management of Type 1 Diabetes in Children
  Nancy L. Beck
  Advances in Pediatrics.2026; 73(1): 121.     CrossRef
• Subcutaneous Catheter Type and Wear Duration in Automated Insulin Delivery Systems: Associations with Glycemic Control in Patients Living with Type 1 Diabetes
  Alexia Aouba, Bleuenn Dreves, Julia Morera, Anne Rod, Mona Guetlin, Michael Joubert
  Diabetes Technology & Therapeutics.2026;[Epub]     CrossRef
• Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA1c (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trial
  Emma G Wilmot, Jacques Beltrand, Bruno Guerci, Aurelie Berot, Helene Hanaire, Elise Bismuth, Pieter Gillard, Marie-Beatrice Saade, Michael Joubert, Randa Saalet, Pratik Choudhary, Rachel Reynaud, Lalantha Leelarathna, Emeline Renard, Sandrine Lablanche, C
  The Lancet Diabetes & Endocrinology.2026; 14(4): 305.     CrossRef
• A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesis
  Rachael J. L. Tan, Anusha Ahuja, Aakanksha Shrestha, Geraldine Gallen, Ben Stotesbury, Yee Cheah, Omar G. Mustafa, Martin B. Whyte, Jonathan Croos, Adam Shooshtarian, Bu' Hussain Hayee, Marietta Stadler
  Diabetes, Obesity and Metabolism.2026; 28(5): 3933.     CrossRef
• Advances in continuous glucose monitoring and their impact on glycemic control in diabetes
  Yi‐Hsuan Lai, Bo‐Jen Chen, Wei‐Hsiang Chuang, Yi‐Der Jiang
  Journal of Diabetes Investigation.2026; 17(4): 557.     CrossRef
• Modernes Diabetesmanagement bei Kindern und Jugendlichen mit Diabetes mellitus Typ 1
  Angela Galler
  Pädiatrie up2date.2026; 21(01): 49.     CrossRef
• The Lived Experiences of Adult Continuous Glucose Monitor Users with Type 1 Diabetes with Recurrent Severe Hypoglycemic Events and Impaired Awareness of Hypoglycemia: A Qualitative Study
  Adriana Boateng-Kuffour, Caitlin S. Kelly, Huyen T. Nguyen, Keval Chandarana, Katherine S. Chapman, Liang Chen, Emilee M. Cornelius, Wendy A. Wolf, William H. Polonsky
  Advances in Therapy.2026; 43(7): 2949.     CrossRef
• Early Initiation of Automated Insulin Delivery at Type 1 Diabetes Diagnosis in Children and Adolescents Is Associated with Improved Outcomes
  Elizabeth A. Mann, Priya Prahalad, Risa Wolf, Nestoras Mathioudakis, Nicole Rioles, Saketh Rompicherla, Ori Odugbesan, Susan Thapa, Robert Vigersky, Osagie Ebekozien
  Diabetes Technology & Therapeutics.2026;[Epub]     CrossRef
• Efficacy and safety of automated insulin delivery system in very young children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials
  Qiongyan Lin, Yongwen Zhou, Mengyun Lei, Ping Ling, Ying Ni, Ziqing Lin, Daizhi Yang, Wen Xu, Hongrong Deng, Jinhua Yan
  Diabetic Medicine.2026;[Epub]     CrossRef
• Exercise-Related Glycemic Fluctuations in Type 1 Diabetes: Mechanisms and Integrated Insulin–Carbohydrate Strategies in the Context of Diabetes Technologies
  Filomena Mazzeo, Gabriele Ferrara, Fiorenzo Moscatelli, Antonietta Monda, Antonietta Messina, Maria Ruberto, Nicola Mancini, Raffaele Ivan Cincione, Gianluca Russo, Salvatore Allocca, Marco La Marra, Pasquale Perrone, Girolamo Di Maio, Maria Casillo, Giov
  Endocrines.2026; 7(2): 22.     CrossRef
• The National Health Insurance Support System for Diabetes Consumables and Management Devices in South Korea: Status, Challenges, and Policy Directions
  Okha Ryu, Yo Han Lee
  Health Insurance Review & Assessment Service Research.2026; 6(1): 46.     CrossRef
• Un nouveau venu : le Réseau d’Investigation de l’Insulinothérapie Automatisée (R2IA)
  Jean-Pierre Riveline, Albatoul Zakaria, Michael Joubert, Guy Fagherazzi, Bruno Detournay, Éric Renard
  Médecine des Maladies Métaboliques.2026;[Epub]     CrossRef
• Foundation Time-Series Models for Local Forecasting in Adults with Type 1 Diabetes Using Continuous Glucose Monitoring Signals
  Roberto Carlos Diaz-Velazco, Alberto Gudiño-Ochoa, Julio Alberto García-Rodríguez, Jorge Ivan Cuevas-Chávez, Eduardo Ruiz-Velázquez
  Technologies.2026; 14(7): 399.     CrossRef
• Advancing Cystic Fibrosis-Related Diabetes Care With Automated Insulin Delivery Systems
  Valeria Grancini, Gianfranco Alicandro, Irene Cogliati, Andreina Oliverio, Laura Zazzeron, Alessia Gaglio, Andrea Gramegna, Valeria Daccò, Giovanna Mantovani, Francesco Blasi, Emanuela Orsi
  Clinical Therapeutics.2026; 48(8): 775.     CrossRef
• Automated insulin delivery systems: An overview and current possibilities
  V. E. Bairova, T. T. Mayarbieva, T. Yu. Demidova
  FOCUS. Endocrinology.2026; 7(2): 46.     CrossRef
• ADJUNCT THERAPIES IN TYPE 1 DIABETES: A REVIEW OF MECHANISMS, MANAGEMENT AND SAFETY OF NEW FORMS OF TREATMENT
  Magda Downar-Zapolska, Agnieszka Mikłaszewicz, Aleksandra Irena Skuza, Emilia Torbacka, Katarzyna Helena Sergiel, Daniel Sagan, Dominik Fidorowicz, Marta Góral, Rafał Siedlecki, Katarzyna Bednarczuk
  International Journal of Innovative Technologies in Social Science.2026;[Epub]     CrossRef
• Transitioning between automated insulin delivery systems: A focus on personalisation
  Pilar Isabel Beato-Víbora, Ana Chico, Jesus Moreno-Fernandez, Sharona Azriel-Mira, Lia Nattero-Chávez, Rosario Vallejo Mora, Núria Alonso-Carril, Olga Simó-Servat, Eva Aguilera-Hurtado, Luz María Reyes Céspedes, Marisol Ruiz de Adana, Marta Domínguez, Ros
  Diabetes Research and Clinical Practice.2025; 222: 112070.     CrossRef
• Advances in Continuous Glucose Monitoring: Clinical Applications
  So Yoon Kwon, Jun Sung Moon
  Endocrinology and Metabolism.2025; 40(2): 161.     CrossRef
• Efficacy and Safety of Automated Insulin Delivery Systems in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis (Diabetes Metab J 2025;49:235-51)
  Wenqi Fan, Chao Deng, Zhiguang Zhou, Xia Li
  Diabetes & Metabolism Journal.2025; 49(3): 520.     CrossRef
• Critical Insights into the Efficacy and Safety of Automated Insulin Delivery Systems in Patients with Type 1 Diabetes Mellitus (Diabetes Metab J 2025;49:235-51)
  Sami Ullah, Ayesha Ahmad, Kamil Ahmad Kamil, Minahil Laraib Asif, Abdullah Jan
  Diabetes & Metabolism Journal.2025; 49(3): 516.     CrossRef
• Automatisierte Insulinabgabesysteme (AID) in der Diabetestherapie: der neue Goldstandard?
  Sandra Schlüter, Dorothee Deiss, Delia Waldenmaier
  Die Diabetologie.2025; 21(8): 840.     CrossRef
• Hypoglycemia incidence and behavioural adjustments during free‐living unstructured physical activity in adults with type 1 diabetes using AID systems: Results from the RAPPID study
  Michael Joubert, Laurent Meyer, Said Bekka, Luc Rakotoarisoa, Nicolas Scheyer, Bleuenn Dreves, Bruno Guerci
  Diabetes, Obesity and Metabolism.2025; 27(12): 7221.     CrossRef
• Improving Time-in-Range in Type 1 Diabetes: Projecting the Clinical and Cost Implications of Automated Insulin Delivery
  Sufyan Hussain, Asli Zeynep Ozdemir Saltik, Jessica J. Yu, Simona de Portu, Richard F. Pollock, Johannes Pöhlmann, Ohad Cohen
  Diabetes Technology & Therapeutics.2025;[Epub]     CrossRef
• Role of automated insulin delivery in managing insulin-treated outpatients with type 2 diabetes: A systematic review and meta-analysis
  Abul Bashar Mohammad Kamrul-Hasan, Joseph M Pappachan, Lakshmi Nagendra, Nazma Akter, Sweekruti Jena, Deep Dutta, Sunil Nair
  World Journal of Diabetes.2025;[Epub]     CrossRef
• A Qualitative Analysis of Provider‐Level Barriers to Prescribing Diabetes Technology
  Jennifer Maizel, Ashby F. Walker, Anna Walls, Francisco J. Pasquel, Michael J. Haller, Brittany S. Bruggeman, Hannah Wesley
  Journal of Diabetes Research.2025;[Epub]     CrossRef
• Bridging the digital divide: student-led literacy initiatives in diabetes management
  Pedro Almeida Moyano, Mohammed Raddaoui, Andrea de Barros Coscelli Ferraz, Gustavo José Martiniano Porfírio, Luciana Aparecida Campos, Ovidiu Constantin Baltatu
  Frontiers in Clinical Diabetes and Healthcare.2025;[Epub]     CrossRef